Global Lateral Flow Assays Market Research Report 2019

2 Global Lateral Flow Assays Quarterly Market Size Analysis

• 2.1 Lateral Flow Assays Business Impact Assessment - COVID-19
  • 2.1.1 Global Lateral Flow Assays Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
• 2.2 Global Lateral Flow Assays Quarterly Market Size 2020-2021
• 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
  • 2.3.1 Drivers
  • 2.3.2 Restraints
  • 2.3.3 Opportunities
  • 2.3.4 Challenges

3 Quarterly Competitive Assessment, 2020

• 3.1 By Players, Global Lateral Flow Assays Quarterly Market Size, 2019 VS 2020
• 3.2 By Players, Lateral Flow Assays Headquarters and Area Served
• 3.3 Date of Key Players Enter into Lateral Flow Assays Market
• 3.4 Key Players Lateral Flow Assays Product Offered
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Impact of Covid-19 on Lateral Flow Assays Segments, By Type

• 4.1 Introduction
  • 1.4.1 Benchtop Readers
  • 1.4.2 Digital/Mobile Readers
  • 1.4.3 Kits & Reagents
• 4.2 By Type, Global Lateral Flow Assays Market Size, 2019-2021

5 Impact of Covid-19 on Lateral Flow Assays Segments, By Application

• 5.1 Overview
  • 5.5.1 Hospitals and Clinics
  • 5.5.2 Diagnostic Laboratories
  • 5.5.3 Pharmaceutical and Biotech Companies
  • 5.5.4 Other End Users
• 5.2 By Application, Global Lateral Flow Assays Market Size, 2019-2021
  • 5.2.1 By Application, Global Lateral Flow Assays Market Size by Application, 2019-2021

6 Geographic Analysis

• 6.1 Introduction
• 6.2 North America
  • 6.2.1 Macroeconomic Indicators of US
  • 6.2.2 US
  • 6.2.3 Canada
• 6.3 Europe
  • 6.3.1 Macroeconomic Indicators of Europe
  • 6.3.2 Germany
  • 6.3.3 France
  • 6.3.4 UK
  • 6.3.5 Italy
• 6.4 Asia-Pacific
  • 6.4.1 Macroeconomic Indicators of Asia-Pacific
  • 6.4.2 China
  • 6.4.3 Japan
  • 6.4.4 South Korea
  • 6.4.5 India
  • 6.4.6 ASEAN
• 6.5 Rest of World
  • 6.5.1 Latin America
  • 6.5.2 Middle East and Africa

7 Company Profiles

• 7.1 Abbott Laboratories
  • 7.1.1 Abbott Laboratories Business Overview
  • 7.1.2 Abbott Laboratories Lateral Flow Assays Quarterly Revenue, 2020
  • 7.1.3 Abbott Laboratories Lateral Flow Assays Product Introduction
  • 7.1.4 Abbott Laboratories Response to COVID-19 and Related Developments
• 7.2 Abbott
  • 7.2.1 Abbott Business Overview
  • 7.2.2 Abbott Lateral Flow Assays Quarterly Revenue, 2020
  • 7.2.3 Abbott Lateral Flow Assays Product Introduction
  • 7.2.4 Abbott Response to COVID-19 and Related Developments
• 7.3 Becton, Dickinson and Company
  • 7.3.1 Becton, Dickinson and Company Business Overview
  • 7.3.2 Becton, Dickinson and Company Lateral Flow Assays Quarterly Revenue, 2020
  • 7.3.3 Becton, Dickinson and Company Lateral Flow Assays Product Introduction
  • 7.3.4 Becton, Dickinson and Company Response to COVID-19 and Related Developments
• 7.4 Biomerieux
  • 7.4.1 Biomerieux Business Overview
  • 7.4.2 Biomerieux Lateral Flow Assays Quarterly Revenue, 2020
  • 7.4.3 Biomerieux Lateral Flow Assays Product Introduction
  • 7.4.4 Biomerieux Response to COVID-19 and Related Developments
• 7.5 Bio-Rad Laboratories
  • 7.5.1 Bio-Rad Laboratories Business Overview
  • 7.5.2 Bio-Rad Laboratories Lateral Flow Assays Quarterly Revenue, 2020
  • 7.5.3 Bio-Rad Laboratories Lateral Flow Assays Product Introduction
  • 7.5.4 Bio-Rad Laboratories Response to COVID-19 and Related Developments
• 7.6 Danaher Corporation
  • 7.6.1 Danaher Corporation Business Overview
  • 7.6.2 Danaher Corporation Lateral Flow Assays Quarterly Revenue, 2020
  • 7.6.3 Danaher Corporation Lateral Flow Assays Product Introduction
  • 7.6.4 Danaher Corporation Response to COVID-19 and Related Developments
• 7.7 Hologic
  • 7.7.1 Hologic Business Overview
  • 7.7.2 Hologic Lateral Flow Assays Quarterly Revenue, 2020
  • 7.7.3 Hologic Lateral Flow Assays Product Introduction
  • 7.7.4 Hologic Response to COVID-19 and Related Developments
• 7.8 Johnson & Johnson
  • 7.8.1 Johnson & Johnson Business Overview
  • 7.8.2 Johnson & Johnson Lateral Flow Assays Quarterly Revenue, 2020
  • 7.8.3 Johnson & Johnson Lateral Flow Assays Product Introduction
  • 7.8.4 Johnson & Johnson Response to COVID-19 and Related Developments
• 7.9 Qiagen
  • 7.9.1 Qiagen Business Overview
  • 7.9.2 Qiagen Lateral Flow Assays Quarterly Revenue, 2020
  • 7.9.3 Qiagen Lateral Flow Assays Product Introduction
  • 7.9.4 Qiagen Response to COVID-19 and Related Developments
• 7.10 Thermo Fisher Scientific
  • 7.10.1 Thermo Fisher Scientific Business Overview
  • 7.10.2 Thermo Fisher Scientific Lateral Flow Assays Quarterly Revenue, 2020
  • 7.10.3 Thermo Fisher Scientific Lateral Flow Assays Product Introduction
  • 7.10.4 Thermo Fisher Scientific Response to COVID-19 and Related Developments
• 7.11 PerkinElmer
  • 7.11.1 PerkinElmer Business Overview
  • 7.11.2 PerkinElmer Lateral Flow Assays Quarterly Revenue, 2020
  • 7.11.3 PerkinElmer Lateral Flow Assays Product Introduction
  • 7.11.4 PerkinElmer Response to COVID-19 and Related Developments
• 7.12 Siemens Healthineers
  • 7.12.1 Siemens Healthineers Business Overview
  • 7.12.2 Siemens Healthineers Lateral Flow Assays Quarterly Revenue, 2020
  • 7.12.3 Siemens Healthineers Lateral Flow Assays Product Introduction
  • 7.12.4 Siemens Healthineers Response to COVID-19 and Related Developments

8 Key Findings

9 Appendix

• 9.1 About US